An International report has been authored on the 22nd of July that places Pharmaust in the top 7 companies that are major players in the 70kDa Ribosomal Protein S6 Kinase Market.
Pharmaust have some serious Intellectual Property Real Estate in the mTOR sector...
It is a paid content report ...on the Apex Market Research Site,, but have asked PAA if they can obtain a copy......
The major players operating into 70 kDa Ribosomal Protein S6 Kinase Market include
: ArQule, Inc.
Astex Pharmaceuticals Inc
Eddingpharm
Merck KGaA
PharmAust Limited
Phoenix Biotechnology, Inc.
Sentinel Oncology Limited
\
from quickly looking at the other companies value,, they would spend more on Coffee and Biscuits than PAA's entire Market Cap...
Looking forward to another positive day ahead,,this time with out the speeding ticket,,, but wasn't that a great response from the comapny , thorough, comprehensive and well explained,,, many have been calling that there is considerable lag on market recognition due for PAA... plenty of Scientific Progress to date that just didn't score on the SP score board,,,
New 52 Week High, page-23
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |